IgA Nephropathy: From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Article
The NephU Community is proud to honor Dr Pranav Garimella as our latest NephHero!
Thank you, Dr Garimella, for your support of and contributions to the NephU Community. We appreciate all you do every day to help patients with kidney disease and their loved… Read MoreA Triple-Header Of Illness: Cardiovascular-Kidney-Metabolic Syndrome
This article discusses the pathophysiology, screening and recommended treatments for cardiovascular-kidney-metabolic syndrome (CKM). Read MoreKidney Disease Improving Global Outcomes (KDIGO) Recommendations For Symptom Burden For Patients Undergoing Dialysis
This article discusses some of the recommendations for healthcare providers to help with managing symptom burden in dialysis patients. Read More2023 Nephrology Highlights & 2024 Forecasts
This article highlights the major points of Nephrology in 2023 and discusses some of the forecasts for 2024. Read MoreConsidering ADPKD Pain Management Strategies
This article reviews the development of the ADPKD pain scale and potential avenues for patient pain relief Read MoreWorking To Overcome Barriers For Hispanics With Kidney Disease & Those At Risk For Kidney Disease
This article discusses Hispanic kidney health statistics and the work being done to overcome barriers when it comes to care. Read MoreIncorporating Social Determinants Of Health Into Nephrology Practice
This article discusses social determinants of health in the context of Nephrology and kidney disease. Read MoreA Focus On The Privatized Approach To Value-Based Care & Addressing Social Determinants Of Health
This article discusses value-based care in kidney disease and its possible assistance in addressing social determinants of health. Read MoreRecognizing & Addressing Symptom Burden For Patients With IgAN
Learn about the impact of symptom burden on patients with Immunoglobulin A nephropathy (IgAN). Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
